DCF — ALBERT EINSTEIN MEDICAL CENTER
Enterprise Value: $-761.8M
🛡️ Public data only — no PHI permitted on this instance.
← DashboardPRFProfileMEMIC MemoBRGBridgeCIComp IntelSCNScenariosAIMLDCFDCFLBOLBOFIN3-StmtMKTMarketDENDenialRETReturnsLVRLeversWFLWaterfallPLYPlaybookTRDTrendsPREDPredictedMEM2Memo
$-761.8M
Enterprise Value
$-254.8M
PV of Cash Flows
$-506.9M
PV of Terminal Value
$-816.4M
Terminal Value
10.0%
WACC
2.5%
Terminal Growth
Cash Flow Projections
PROJ| Year | Revenue | EBITDA | Margin | FCF | PV(FCF) |
|---|---|---|---|---|---|
| Year 1 | $887.1M | $-39.9M | -4.0% | $-77.5M | $-70.4M |
| Year 2 | $913.8M | $-32.0M | -3.0% | $-70.7M | $-58.4M |
| Year 3 | $941.2M | $-23.5M | -2.0% | $-63.4M | $-47.6M |
| Year 4 | $969.4M | $-19.4M | -2.0% | $-60.4M | $-41.3M |
| Year 5 | $998.5M | $-17.5M | -2.0% | $-59.7M | $-37.1M |
Interpretation
INTAt a WACC of 10.0% and terminal growth of 2.5%, enterprise value is $-761.8M. Terminal value accounts for 0% of total EV — consider sensitivity to terminal assumptions.
Next steps: Check the LBO model to see equity returns at this entry price, or the EBITDA bridge to model value creation levers.
Assumptions
ASSMrevenue base$861.3M
revenue growth rates[0.03, 0.03, 0.03, 0.03, 0.03]
ebitda margin base-0.04999999953559125
ebitda margin improvement bps[50, 100, 100, 50, 25]
capex pct revenue0.04
nwc pct revenue0.08
tax rate0.25
projection years5